Allogene Therapeutics (ALLO) Operating Leases (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Operating Leases of $70.35 million in Q2 2026, down 11.2% from $79.24 million a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Operating Leases (2018 - 2026) Analysis & Trends
At the end of FY2025, Allogene Therapeutics reported Operating Leases of $75.05 million, down 9.9% from FY2024.
- Annual Operating Leases has declined for three straight years, though with a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $83.25 million in FY2024 (-5.8%), $88.35 million in FY2023 (-7.1%), $95.12 million in FY2022 (+36.0%) and $69.93 million in FY2021 (+37.6%).
- The Q2 2026 figure is the lowest quarterly Operating Leases since Q1 2022.
- On a year-over-year basis, Operating Leases has declined for 13 consecutive quarters, with an average decline of 8.7% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 91.8% in Q2 2022, against a decline of 11.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $72.63 million (Q1 2026), $75.05 million (Q4 2025) and $77.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Allogene Therapeutics | 562.91 Mn | 562.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.35 Mn |
| Mar 31, 2026 | 72.63 Mn |
| Dec 31, 2025 | 75.05 Mn |
| Sep 30, 2025 | 77.13 Mn |
| Jun 30, 2025 | 79.24 Mn |
| Mar 31, 2025 | 81.29 Mn |
| Dec 31, 2024 | 83.25 Mn |
| Sep 30, 2024 | 85.14 Mn |
| Jun 30, 2024 | 86.99 Mn |
| Mar 31, 2024 | 88.92 Mn |
| Dec 31, 2023 | 88.35 Mn |
| Sep 30, 2023 | 90.10 Mn |
| Jun 30, 2023 | 91.82 Mn |
| Mar 31, 2023 | 93.51 Mn |
| Dec 31, 2022 | 95.12 Mn |
| Sep 30, 2022 | 96.71 Mn |
| Jun 30, 2022 | 98.23 Mn |
| Mar 31, 2022 | 69.04 Mn |
| Dec 31, 2021 | 69.93 Mn |
| Sep 30, 2021 | 50.64 Mn |
API Access
Allogene Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();